# Intravenous Lidocaine Versus Morphine for Severe Pain in the ED

> **NCT02912195** · PHASE4 · COMPLETED · sponsor: **Alameda Health System** · enrollment: 32 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Intravenous lidocaine
- **DRUG:** Intravenous morphine

## Key facts

- **NCT ID:** NCT02912195
- **Lead sponsor:** Alameda Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02912195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02912195, "Intravenous Lidocaine Versus Morphine for Severe Pain in the ED". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02912195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*